Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 50003410
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470378(CHEMBL108283)
Affinity DataIC50: 20nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470365(CHEMBL326664)
Affinity DataIC50: 45nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470374(CHEMBL322325)
Affinity DataIC50: 54nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470371(CHEMBL325543)
Affinity DataIC50: 63nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470361(CHEMBL108404)
Affinity DataIC50: 116nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470369(CHEMBL325588)
Affinity DataIC50: 226nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470357(CHEMBL321473)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM87351(m-AMSA | N-[4-(acridin-9-ylamino)-3-methoxyphenyl]...)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470360(CHEMBL109928)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470362(CHEMBL444329)
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470364(CHEMBL111592)
Affinity DataIC50: 2.97E+3nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470367(CHEMBL109942)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470375(CHEMBL111261)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470373(CHEMBL326274)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470372(CHEMBL322491)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470355(CHEMBL320354)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470363(CHEMBL111735)
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470359(CHEMBL320495)
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470376(CHEMBL109880)
Affinity DataIC50: 5.00E+4nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470370(CHEMBL109468)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470368(CHEMBL111502)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470366(CHEMBL109534)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470377(CHEMBL108493)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470358(CHEMBL109922)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed
TargetDNA topoisomerase 2-alpha/2-beta(Human)
Sloan-Kettering Institute For Cancer Research

Curated by ChEMBL
LigandPNGBDBM50470356(CHEMBL109743)
Affinity DataIC50: 1.00E+5nMAssay Description:In vitro 50% inhibition of topoisomerase II mediated k-DNA decatenationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2020
Entry Details Article
PubMed